The gastroparesis market is poised for significant growth, driven by the emergence of novel therapeutic classes such as the Dopamine D2 receptor antagonist (GIMOTI). Meanwhile, novel therapies like ...
Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) stock is surging on Wednesday, without any news to justify the movement. Session volume stands at 69.3 million versus the average volume of 26.9 million, ...
Crinetics Pharmaceuticals (Nasdaq: CRNX), a pharmaceutical company focused on the discovery, development, and commercialization of the next generation of therapeutics for patients with endocrine and ...
Municipal wastewater treatment plants are ineffective at removing Prozac (fluoxetine) and other common pharmaceuticals in wastewater, causing the drugs to be discharged into lakes, rivers and streams ...
Dr. Makary is the commissioner of the Food and Drug Administration. Before joining the F.D.A., he was a surgeon at Johns Hopkins University School of Medicine. American drug advertisements are filled ...
This AI company isn't yet living up to the hype. Let's discuss Recursion Pharmaceuticals' performance over the past four years and whether the company can deliver solid returns in the future. It can ...
VERO BEACH, Fla., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA), a clinical-stage biopharmaceutical company developing Next Generation Cancer (NGC) therapies for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback